Acarix AB (publ) (FRA:7AC)
Germany · Delayed Price · Currency is EUR 0.0224
-0.0001 (-0.44%)
At close: Dec 1, 2025
Acarix AB Company Description
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out.
The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow.
It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States.
The company was founded in 2009 and is headquartered in Malmö, Sweden.
Acarix AB (publ)
| Country | Sweden |
| Founded | 2009 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 8 |
| CEO | Aamir Mahmood |
Contact Details
Address: Regus MalmOe Malmö, 215 32 Sweden | |
| Website | acarix.com |
Stock Details
| Ticker Symbol | 7AC |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Aamir Mahmood | Chief Executive Officer |
| Christian Lindholm | Chief Financial Officer |
| Carma Connely | Chief Operating Officer |